These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1819151)

  • 1. Molecular modeling of antipsychotic drugs and G protein coupled receptors.
    Dahl SG; Edvardsen O; Sylte I
    Therapie; 1991; 46(6):453-9. PubMed ID: 1819151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of interactions between tetrahydroprotoberberines and dopamine receptors.
    Tang Y; Chen KX; Jiang HL; Jin GZ; Ji RY
    Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):8-12. PubMed ID: 8737443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors.
    Hibert MF; Trumpp-Kallmeyer S; Bruinvels A; Hoflack J
    Mol Pharmacol; 1991 Jul; 40(1):8-15. PubMed ID: 1649965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics of dopamine at the D2 receptor.
    Dahl SG; Edvardsen O; Sylte I
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8111-5. PubMed ID: 1910173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
    Monsma FJ; Shen Y; Ward RP; Hamblin MW; Sibley DR
    Mol Pharmacol; 1993 Mar; 43(3):320-7. PubMed ID: 7680751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide interactions with G-protein coupled receptors.
    Marshall GR
    Biopolymers; 2001; 60(3):246-77. PubMed ID: 11774230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PREDICT modeling and in-silico screening for G-protein coupled receptors.
    Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
    Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of sigma 1 receptor ligands: a model of binding conformational and electrostatic considerations.
    Gund TM; Floyd J; Jung D
    J Mol Graph Model; 2004 Jan; 22(3):221-30. PubMed ID: 14629980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
    Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
    Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling of ligand-receptor interactions in GABA C receptor.
    Osolodkin DI; Chupakhin VI; Palyulin VA; Zefirov NS
    J Mol Graph Model; 2009 Apr; 27(7):813-21. PubMed ID: 19167917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional model of the human PAF receptor.
    Kajihara A; Komooka H; Kamiya K; Yoneda T; Yoneda S; Nakamura M; Shimizu T; Umeyama H
    J Lipid Mediat Cell Signal; 1994 May; 9(3):185-96. PubMed ID: 7921778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug design strategies for targeting G-protein-coupled receptors.
    Klabunde T; Hessler G
    Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling of mu opioid receptor and its interaction with ohmefentanyl.
    Tang Y; Chen KX; Jiang HL; Wang ZX; Ji RY; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):156-60. PubMed ID: 9772668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template.
    Indarte M; Madura JD; Surratt CK
    Proteins; 2008 Feb; 70(3):1033-46. PubMed ID: 17847094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.